Related Experiment Video
Updated: Aug 18, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Ethiopathogenesis, diagnosis and prevention of vascular calcification in end stage renal disease
Emiliana Ferramosca1, Antonio Bellasi, Carlo Ratti
1Tulane University School of Medicine, 1430 Tulane Avenue, SL-48, New Orleans, LA, 70112, USA.
Insights
Vascular calcification and atherosclerosis are common in end-stage renal disease (ESRD), driven by metabolic issues and inflammation. This process is a regulated, bone-like mineralization, not just passive crystal deposition.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Pathology
Background:
- End-stage renal disease (ESRD) patients exhibit high rates of atherosclerosis and vascular calcification, contributing to cardiovascular disease.
- Traditional risk factors inadequately explain the elevated cardiovascular disease incidence in ESRD.
- Vascular calcification in ESRD involves both intimal and medial layers, with distinct cellular and pathological characteristics.
Purpose of the Study:
- To review the etiopathogenesis of vascular calcification in ESRD.
- To discuss modern imaging modalities for detecting vascular calcification.
- To outline current therapeutic strategies for managing vascular calcification progression in ESRD.
Main Methods:
- Literature review focusing on the pathophysiology of vascular calcification in ESRD.
- Analysis of studies on imaging techniques for vascular calcification detection.
- Synthesis of information on therapeutic interventions for ESRD-related vascular calcification.
Main Results:
- Vascular calcification in ESRD is a complex, regulated process involving vascular smooth muscle cell (VSMC) phenotype changes and bone metabolism proteins.
- Metabolic abnormalities (calcium-phosphate) and inflammation in ESRD are key contributors to vascular calcification.
- Vascular calcification is not merely passive hydroxyapatite deposition but an active, biologically regulated phenomenon.
Conclusions:
- Vascular calcification in ESRD is a regulated, active process resembling bone formation, influenced by uremic metabolic and inflammatory states.
- Early detection and targeted therapies are crucial for managing cardiovascular risk in ESRD patients.
- Understanding the molecular mechanisms of vascular calcification is essential for developing novel treatments.
Abstract:
Extensive atherosclerosis and heavy vascular and valvular calcifications are common complications of end stage renal disease (ESRD) and are very likely related to the high incidence of cardiovascular disease in these patients. The greatly increased incidence of cardiovascular disease is only partly explained by traditional risk factors for atherosclerosis. In ESRD, vascular calcification occurs both in the vascular intima layer and in the tunica media. Intimal calcification is disseminated and is characteristically associated with damaged and abnormally functioning endothelium, and macrophage and vascular smooth muscle cell (VSMC) infiltration typical of atherosclerosis. On the contrary, medial calcification occurs in patchy distribution and the most frequent cell types found in its vicinity are the VSMC and macrophage. The uremic state is associated with numerous metabolic abnormalities and endocrine disturbances primarily involving calcium and phosphorus metabolism. Furthermore, chronic kidney disease and dialysis are considered states of active and strong inflammatory response. These dysfunctions occur early in the course of renal failure and likely contribute to the development and progression of vascular calcification and atherosclerosis. For many years, vascular calcification was considered solely the result of a passive deposition of hydroxyapatite crystals in the arterial wall due to elevated calcium-phosphate ion product. However, a large body of evidence has now shown that this is a highly regulated process governed by factors that closely resemble calcium deposition in bone tissue. In fact, vascular calcification requires changes in the phenotype of VSMC and the expression of several proteins normally involved in bone metabolism. This review is centered on the etiopathogenesis of vascular calcification in ESRD, its detection with modern imaging modalities and the therapeutic approaches currently available to slow its progression.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease II: Clinical Manifestations
Urinary Tract Calculi I: Introduction

